Major Depressive Disorder (MDD) constitutes a considerable burden for the individual patient and for society, ranking highest on the WHO list of diseases that estimate Disability-Adjusted Life Years (DALY) [
1,
2]. MDD is common with a global prevalence of approx. 3–6% [
3,
4]. The most severely depressed patients are admitted to psychiatric inpatient wards. Even though patients improve substantially during their stay they are usually still not fully recovered when discharged [
5,
6], leaving them at risk of depression worsening, and consequent readmission [
7‐
9]. The suicidal risk in recently discharged patients with MDD has also been found to be markedly increased [
10]. Thus, newly discharged patients constitute a very vulnerable group.
The presence of substantial depressive symptoms at discharge necessitates immediate outpatient follow-up treatment. Danish guidelines recommend that the transition period between inpatient and outpatient treatment should be as short as possible. It is also mandatory, according to Danish National quality standards, for all patients to have an appointment with a relevant outpatient health service before discharge [
11]. Patients on inpatient psychiatric wards join a predictable and structured milieu with regular meals, physical activities, sleep schedules, medication administration, and round-the-clock care. The transition from inpatient to outpatient status is reported by many patients to be difficult due to the shift from a protective and structured supportive hospitalization environment to being left more to themselves [
12].
To this end, there is an urgent need for new tools and treatment methods to be implemented to support patients in this transition.
Electronic self-monitoring
In recent years, an increasing number of studies have been performed using electronic self-help interventions for depression and anxiety disorders. In general, research points to electronic self-help interventions as useful, and in some cases with efficacy equal to face-to-face therapy [
13]. However, for
clinical depression, therapist-assisted treatment has been shown to be superior to predominantly self-help computer-based cognitive and behavioral interventions [
14]. In depression, low education level has been found to increase the risk of symptom deterioration when using these interventions [
15]. Adherence seems to be quite high, but dependent on disease severity, treatment length and chronicity [
16].
In our previous feasibility study, we developed an electronic monitoring system Daybuilder (now Monsenso Daybuilder = MDB) for use with patients suffering from MDD [
6]. The system was found to be reliable and easy to use, even for patients recently treated with Electroconvulsive Treatment. Patients had a high adherence rate and were satisfied with the usability of the program with a System Usability Score of 86.2 (SD = 9.7) (100 as maximum). This system is now used in the present study with some minor alterations: a possibility of entering daily registration of activity (from a Fitbit bracelet), graphical display of sleep instability, text fields to enter a qualitative description of sleep quality, and text fields to enter any used measures to control the sleep-wake cycle. Furthermore, the graphical interface has been improved for better clarity of sleep and mood patterns.
Sleep, circadian rhythms, and zeitgebers
The human circadian clock, residing in the suprachiasmatic nuclei (SCN) of the hypothalamus, has an intrinsic period averaging 24.2 h [
17]. To synchronize with the astronomical 24-h day the period is continually adjusted through external zeitgebers stimuli (external synchronization). Zeitgebers are stimuli capable of synchronizing circadian rhythms such as sleep, melatonin, temperature, heart rate, and blood pressure to provide a stable 24-h rhythm (entrainment). The strongest zeitgeber is light [
18], while food [
19], exercise [
20], and social contact [
21], although considered as weaker zeitgebers, can probably also modulate the circadian phase adjustment in humans. Social zeitgebers (e.g. work schedules) act directly or indirectly as they influence the timing of meals, sleep, exercise, and outdoor light exposure. The effect of zeitgeber stimuli is dependent on their intensity and temporal distribution during the 24-h sleep-wake cycle. This has been most extensively described for light where a Phase Response Curve (PRC) [
22] shows the advancing or delaying effect of light on the circadian clock dependent on the time of day. Entrainment by light is mediated by the retina, mainly through the intrinsic photoreceptive Retinal Ganglion Cells (ipRGCs) to the SCN and to other brain regions [
23,
24].
The setting of peripheral clocks, for example in liver and muscle cells [
25], are orchestrated from the SCN in a hierarchical way and influenced by sleep quality, probably mediated through light exposure at night [
26]. The exact biological mechanism underlying the synchronization between the SCN and peripheral clocks is not fully understood but is supposed to work through the sympathetic nervous system and through humoral signals such as hormones (glucocorticoids) and cytokines [
27]. Recently, we have become aware that peripheral rhythms can be out of synchrony with each other, and thus also out of sync with the orchestrating SCN signals (internal desynchronization) [
28]. In depression, there is clear evidence of circadian and seasonal rhythms dysfunction [
29], clinically seen as early morning awakening and associated diurnal variation in mood [
30], as an advancement of REM sleep within the sleep period [
31], as a seasonal recurrence of depression, and as circadian and seasonal variation in neurotransmitters [
32,
33]. Desynchronization between the rhythm of the peripheral body clocks, for instance in muscle and liver cells, can be brought about by changes in the timing of exercise [
34], meals [
35], social activity [
36], and maybe sleep [
37].
External and internal desynchronization can thus be caused by inappropriate strength and timing of zeitgeber signals due to depression-related alterations in circadian behavior. This includes eating at night, avoiding daylight, light at night, or social isolation with alterations in sleep schedule [
38].
Sleep disturbances are present in 50–90% of patients with depression [
39]. The biological basis for sleep disturbances in depressed patients are not fully elucidated, but there is evidence for a circadian component such as misaligned morning cortisol increase [
40], diurnal variation in mood with evening improvement, staying up late [
41], and even inappropriate light habits [
42]. Forced changes in the timing of the sleep-wake cycle are often linked to corresponding changes in depression severity. Thus, a sleep-phase delay has been shown to worsen depression [
43], and sleep phase advance and sleep deprivation have a well-established antidepressant effect [
44,
45]. Furthermore, daytime naps induce hour-long mood drops in a large proportion of depressed patients [
46]. Our usability study, using electronic monitoring that documented sleep patterns over a four-week period in patients recently discharged from a mental health hospital, found a day-to-day highly variable sleep-wake cycle with gradually delayed sleep and unstable mood [
6].
Therefore, enforcement and timing of zeitgebers with a focus on the regulation of the sleep-wake cycle present itself as a possible new treatment method. In this study we will help patients to attain a time-structured environment with regularly timed zeitgeber stimuli: daylight exposure, exercise, meals, and social contact, to sustain a stable sleep cycle. We have coined this newly proposed intervention: Circadian Reinforcement Therapy (CRT).